FDA's Apparent Requirement for Additional Thesis

Total Length: 364 words ( 1 double-spaced pages)

Total Sources: 1

The philosophy behind clinical trials goes back nearly fifty years, to the Kefauver-Harris Drug Amendments. The objective of a trial is twofold -- to understand the benefits and risks of a drug. The FDA has an obligation to the public that is just as great if not greater than their obligation to the industry. They are willing to support the industry through the most important approvals processes when necessary, such as with AZT. From the researcher's point-of-view, the requirements for additional data may be a pain, but they are also a pain for the FDA as well because of the additional resources they must dedicate to analyzing that data. There are a lot of sides to this debate.

Stuck Writing Your "FDA's Apparent Requirement for Additional" Thesis?

From the point-of-view of the researcher or the drug company, additional trial requirements and demand for larger data sets may be onerous, but it is worth considering the issue in the context of all stakeholders.

Works.....

     Open the full completed essay and source list


OR

     Order a one-of-a-kind custom essay on this topic


sample essay writing service

Cite This Resource:

Latest APA Format (6th edition)

Copy Reference
"FDA's Apparent Requirement For Additional" (2009, November 16) Retrieved June 6, 2026, from
https://www.aceyourpaper.com/essays/fda-apparent-requirement-additional-17450

Latest MLA Format (8th edition)

Copy Reference
"FDA's Apparent Requirement For Additional" 16 November 2009. Web.6 June. 2026. <
https://www.aceyourpaper.com/essays/fda-apparent-requirement-additional-17450>

Latest Chicago Format (16th edition)

Copy Reference
"FDA's Apparent Requirement For Additional", 16 November 2009, Accessed.6 June. 2026,
https://www.aceyourpaper.com/essays/fda-apparent-requirement-additional-17450